EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Immunogenic Cell Death‐Associated miRNAs in the Tumor Microenvironment of Hepatocellular Carcinoma

Anrong Jiang, Yun-Qi Mo, Ying Wang, Kuncheng Qiu, Yi-Ran Ni, Lan Ma, Rui-Tao Zhang, Yan-Qiong Zhang, Jiangfeng Wu, Bo-Tao Li

Journal of Surgical Oncology · 2026-11 · 134 (6) · 793-804

DOI: 10.1002/jso.70363 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Surgical Oncology, online erschienen am 03.09.2026. Verfasst von Anrong Jiang und 9 weiteren Autor:innen. Beteiligte Einrichtung: The First College of Clinical Medical Science, China Three Gorges University, Yichang, China. Hauptthemen laut MEDLINE: MicroRNAs, Carcinoma, Hepatocellular, Liver Neoplasms, Tumor Microenvironment. Die Arbeit nennt 153 Literaturangaben. Gefördert von: National Natural Science Foundation of China, State Key Laboratory Special Fund, Chinese Academy of Medical Sciences Initiative for Innovative Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocellular carcinoma (HCC) poses significant therapeutic challenges due to its high heterogeneity and immunosuppressive tumor microenvironment (TME). Immunogenic cell death (ICD) represents a promising strategy in cancer therapy by eliciting antitumor immune responses through the controlled release of damage‐associated molecular patterns (DAMPs). However, its therapeutic efficacy remains substantially limited by the immunosuppressive TME and the lack of selective targeting of conventional ICD‐inducing agents. MicroRNAs (miRNAs) regulate immune checkpoints (e.g., PD‐L1), TME populations (e.g., tumor‐associated macrophages and regulatory T cells), and DAMPs‐related pathways, positioning them to both enhance ICD and relieve its constraints. Clinical translation, however, is hindered by delivery and off‐target effects. Emerging nanotechnologies, including pH‐responsive and photoresponsive carriers, enable spatiotemporal co‐delivery of ICD inducers (e.g., oxaliplatin) and miRNA modulators (e.g., anti‐miR‐21), thereby augmenting DAMP release, reprogramming the TME, and targeting competing endogenous RNA networks (e.g., lncRNA H19) to overcoming resistance. In this Review, with a focus on clinical translation, we argue that combining ICD, immune checkpoint blockade, and miRNA modulation offers a coherent framework to turn cold HCC tumors into responsive ones, thereby increasing treatment precision and sustaining benefit.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsCarcinoma, HepatocellularLiver NeoplasmsTumor MicroenvironmentImmunogenic Cell DeathHumansAnimals

Substanzen

MicroRNAs

Autor:innen und Institutionen

  • The First College of Clinical Medical Science, China Three Gorges University, Yichang, China.
  • College of Medicine and Health Sciences, China Three Gorges University, Yichang, China.
  • Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, Yichang, China.
  • Institute of Organ Fibrosis and Targeted Drug Delivery, China Three Gorges University, Yichang, China.
  • College of Basic Medical Science, China Three Gorges University, Yichang, China.
  • Institute of Organ Fibrosis and Targeted Drug Delivery, The People's Hospital, China Three Gorges University, Yichang, China.

Förderung

  • National Natural Science Foundation of China
  • State Key Laboratory Special Fund
  • Chinese Academy of Medical Sciences Initiative for Innovative Medicine
  • The State Key Laboratory of Anti-Infective Drug Development
  • Open Foundation of Hubei Province Key Laboratory of Tumor Microenvironment and immunotherapy

Zitieren

APA

Jiang, A., Mo, Y. Q., Wang, Y., Qiu, K., Ni, Y. R., Ma, L., Zhang, R. T., Zhang, Y. Q., Wu, J., & Li, B. T. (2026). Immunogenic Cell Death‐Associated miRNAs in the Tumor Microenvironment of Hepatocellular Carcinoma. Journal of Surgical Oncology, 134(6), 793-804. https://doi.org/10.1002/jso.70363

Vancouver

Jiang A, Mo YQ, Wang Y, Qiu K, Ni YR, Ma L, et al. Immunogenic Cell Death‐Associated miRNAs in the Tumor Microenvironment of Hepatocellular Carcinoma. Journal of Surgical Oncology. 2026;134(6):793-804. doi:10.1002/jso.70363

BibTeX
@article{Jiang2026,
  author = {Jiang, Anrong and Mo, Yun-Qi and Wang, Ying and Qiu, Kuncheng and Ni, Yi-Ran and Ma, Lan and Zhang, Rui-Tao and Zhang, Yan-Qiong and Wu, Jiangfeng and Li, Bo-Tao},
  title = {Immunogenic Cell Death‐Associated miRNAs in the Tumor Microenvironment of Hepatocellular Carcinoma},
  journal = {Journal of Surgical Oncology},
  year = {2026},
  volume = {134},
  number = {6},
  pages = {793--804},
  doi = {10.1002/jso.70363}
}
Kostenlos starten →